Table 3.
Effector miRNA | Target genes | Validation assay | Year | Reference | ||||
---|---|---|---|---|---|---|---|---|
Expressiona | Reporterb | qRT-PCR | ISc | siRNAd | ||||
miR-372 and -373 | LATS2 | + | + | + | + | 2006 | [40] | |
miR-221 and -222 | p27Kip1 | + | + | 2007 | [45] | |||
miR-315 | Axin and Notum | + | 2007 | [110] | ||||
miR-34a | Bcl2 and MYCN | + | 2008 | [111] | ||||
miR-373 and -520c | CD44 | + | + | 2008 | [101] | |||
miR-29a, b, c | p85α and CDC42 | + | + | 2009 | [38] | |||
miR-192 and -194 | Per1, 2 and 3 | + | 2009 | [102] | ||||
28 miRNAs | p21Cip/Waf1 | + | + | 2010 | [46] | |||
10 miRNAs | MCL1 | + | 2010 | [99] | ||||
miR-1285 | p53 | + | + | + | 2010 | [39] | ||
miR-504 | p53 | + | + | 2010 | [10] | |||
11 miRNAs | Multiple genes | + | 2010 | [105] | ||||
miR-491 | Bcl-xL | + | + | + | 2010 | [11] | ||
28 miRNAs | p21Cip/Waf1 | + | + | 2010 | [114] |
a mRNA expression profiling.
b Luciferase and/or GFP reporter assays.
c Immunostaining.
d Recapitulation of miRNA-mediated phenotype by selected siRNAs.